Back
Soleno Therapeutics Vs. KalVista Pharmaceuticals Industry Stock Comparison
Buy
60
SLNO
Soleno Therapeutics
Last Price:
55.74
Seasonality Move:
33.56%
Sell
48
KALV
KalVista Pharmaceuticals
Last Price:
10.46
Seasonality Move:
3.67%
Buy
60
Soleno Therapeutics (SLNO)
is a Buy
Is Soleno Therapeutics a Buy, Sell or Hold?
- The current Soleno Therapeutics [SLNO] share price is $57.31. The Score for SLNO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- SLNO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
KalVista Pharmaceuticals (KALV)
is a Sell
Is KalVista Pharmaceuticals a Buy, Sell or Hold?
- The current KalVista Pharmaceuticals [KALV] share price is $10.67. The Score for KALV is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- KALV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SLNO Stock Price Chart
What is Soleno Therapeutics's stock price today?
-
The Soleno Therapeutics share price today is $57.31
The current trend is moderately bullish and SLNO is experiencing selling pressure, which indicates risk of future bearish movement.
KALV Stock Price Chart
What is KalVista Pharmaceuticals's stock price today?
-
The KalVista Pharmaceuticals share price today is $10.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KALV is experiencing selling pressure, which indicates risk of future bearish movement.
SLNO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.64 | Buy |
| Relative Strength Index (14 RSI): | 60.56 | Buy |
| Chaikin Money Flow: | -278402 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.88 - 56.86) | Buy |
| Bollinger Bands (100): | (44.69 - 53.77) | Buy |
KALV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 42.43 | Sell |
| Chaikin Money Flow: | -273120 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.98 - 12.12) | Sell |
| Bollinger Bands (100): | (10.92 - 13.5) | Sell |
SLNO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57 | Buy |
| 20-day SMA: | 55.46 | Buy |
| 50-day SMA: | 52.36 | Buy |
| 200-day SMA: | 46.69 | Buy |
| 8-day EMA: | 57.05 | Buy |
| 20-day EMA: | 55.51 | Buy |
| 50-day EMA: | 52.9 | Buy |
| 200-day EMA: | 44.83 | Buy |
KALV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.16 | Sell |
| 20-day SMA: | 11.59 | Sell |
| 50-day SMA: | 11.37 | Sell |
| 200-day SMA: | 12.36 | Sell |
| 8-day EMA: | 11.14 | Sell |
| 20-day EMA: | 11.34 | Sell |
| 50-day EMA: | 11.58 | Sell |
| 200-day EMA: | 11.79 | Sell |
Soleno Therapeutics Earnings Growth & SLNO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
KalVista Pharmaceuticals Earnings Growth & KALV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.07 per share.
Soleno Therapeutics Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
KalVista Pharmaceuticals Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||